Next Article in Journal
Role of the Extremolytes Ectoine and Hydroxyectoine as Stress Protectants and Nutrients: Genetics, Phylogenomics, Biochemistry, and Structural Analysis
Next Article in Special Issue
Journey into Bone Models: A Review
Previous Article in Journal
Is There Still Any Role for Oxidative Stress in Mitochondrial DNA-Dependent Aging?
Previous Article in Special Issue
Cell-Free Approaches in Synthetic Biology Utilizing Microfluidics
Open AccessArticle

Bioprinting Perfusion-Enabled Liver Equivalents for Advanced Organ-on-a-Chip Applications

1
Cellbricks GmbH, 13355 Berlin, Germany
2
Fachgebiet für Medizinische Biotechnologie, Technische Universität Berlin, 13355 Berlin, Germany
*
Author to whom correspondence should be addressed.
Genes 2018, 9(4), 176; https://doi.org/10.3390/genes9040176
Received: 5 February 2018 / Revised: 8 March 2018 / Accepted: 19 March 2018 / Published: 22 March 2018
(This article belongs to the Special Issue From the Lab-on-a-Chip to the Organ-on-a-Chip)
Many tissue models have been developed to mimic liver-specific functions for metabolic and toxin conversion in in vitro assays. Most models represent a 2D environment rather than a complex 3D structure similar to native tissue. To overcome this issue, spheroid cultures have become the gold standard in tissue engineering. Unfortunately, spheroids are limited in size due to diffusion barriers in their dense structures, limiting nutrient and oxygen supply. Recent developments in bioprinting techniques have enabled us to engineer complex 3D structures with perfusion-enabled channel systems to ensure nutritional supply within larger, densely-populated tissue models. In this study, we present a proof-of-concept for the feasibility of bioprinting a liver organoid by combining HepaRG and human stellate cells in a stereolithographic printing approach, and show basic characterization under static cultivation conditions. Using standard tissue engineering analytics, such as immunohistology and qPCR, we found higher albumin and cytochrome P450 3A4 (CYP3A4) expression in bioprinted liver tissues compared to monolayer controls over a two-week cultivation period. In addition, the expression of tight junctions, liver-specific bile transporter multidrug resistance-associated protein 2 (MRP2), and overall metabolism (glucose, lactate, lactate dehydrogenase (LDH)) were found to be stable. Furthermore, we provide evidence for the perfusability of the organoids’ intrinsic channel system. These results motivate new approaches and further development in liver tissue engineering for advanced organ-on-a-chip applications and pharmaceutical developments. View Full-Text
Keywords: bioprinting; stereolithography; liver equivalent; tissue engineering; bioink; 3D cell-culture; toxin testing; in vitro testing; drug development bioprinting; stereolithography; liver equivalent; tissue engineering; bioink; 3D cell-culture; toxin testing; in vitro testing; drug development
Show Figures

Figure 1

MDPI and ACS Style

Grix, T.; Ruppelt, A.; Thomas, A.; Amler, A.-K.; Noichl, B.P.; Lauster, R.; Kloke, L. Bioprinting Perfusion-Enabled Liver Equivalents for Advanced Organ-on-a-Chip Applications. Genes 2018, 9, 176.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop